Further investigations are warranted to validate these findings in East Asian populations, including Japanese cohorts
GLP-1s have changed the landscape for obesity care, and people who take them should know what to expect with these treatments, as being prepared may help with long-term success, says Kimberly Gudzune, MD, MPH, a board-certified obesity medicine physician and affiliate faculty at the Johns Hopkins Bloomberg School of Public Health in Baltimore
Tirzepatide is the first dual GIP/GLP-1 receptor co-agonist to win FDA approval for type 2 diabetes
GLP-1 is a medication used for weight loss, to treat type 2 diabetes and to reduce the risk of major adverse cardiovascular events
Very easy to navigate the order process
At Chipotle, diners can order double high-protein burritos with twice the meat and no rice